Qiagen NV | QIA - Cost Of Sales


Qiagen NV reported $217.43M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
argenx SE USD 121M 28.69M Mar/2026
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 677M 89M Mar/2026
Qiagen NV USD 217.43M 29.65M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026